Medication | Addiction Professional Magazine Skip to content Skip to navigation


No time for petty conflict amid an opioid crisis

March 12, 2018  |  Gary A. Enos, Editor
The opening session of the American Association for the Treatment of Opioid Dependence (AATOD) conference emphasized putting to rest old internal conflicts about treatment.

SCE: Be open to evidence-based treatment

March 9, 2018  |  Julie Miller, Editor in Chief
Experts speaking in Chicago at the Summit For Clinical Excellence, The Opioid Crisis: Strategies for Treatment and Recovery covered a number of treatment modalities that clinicians might not be embracing just yet.

New York regulators pave the way for expanded detox

March 6, 2018  |  Gary A. Enos, Editor
At least temporarily, New York hospitals will receive relief from state requirements associated with providing hospital-based detox services to opioid-dependent patients.

Five takeaways from panel event on stimulants

February 26, 2018  |  Gary A. Enos, Editor
Last week's National Conference on Addiction Disorders Panel Series event placed into perspective the profession's fears about addressing rising use of stimulants.

Study offers reasons why alcohol medication adherence poses challenge

February 15, 2018  |  Gary A. Enos, Editor
Research reveals several factors that influence the ability of patients with an alcohol use disorder to stay on a daily medication regimen, including intense cravings and a weekend danger.

Nurses, peers pivotal to health system's opioid disorder initiative

February 12, 2018  |  Gary A. Enos, Editor
Leaders at Christiana Care Health System say efforts to identify and address opioid use disorders in hospital settings should not be confined to the emergency room.

Addiction groups target primary care in effort to boost opioid crisis response

February 5, 2018  |  Gary A. Enos, Editor
Groups led by the American Academy of Addiction Psychiatry say primary care organizations need substance use disorder training that goes beyond simply certifying more prescribers.

Today's treatments oversimplify the disease of addiction

January 16, 2018  |  Roland Reeves, MD
The progression of addiction and other diseases is relentless unless treatment takes a comprehensive and long-range approach.

Researchers explore medications' possible role in fighting methamphetamine

December 21, 2017  |  Gary A. Enos, Editor
Research at the University of Florida is focusing on sigma-1 receptor agonists as a possible drug intervention for individuals in treatment for methamphetamine addiction.

Professionals weigh responses to re-emergence of stimulants

December 7, 2017  |  Gary A. Enos, Editor
Readers discuss whether and how the community will respond to signs of a growing cocaine/stimulant crisis.

FDA approves once-monthly injectable buprenorphine product

December 1, 2017  |  Tom Valentino, Senior Editor
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.

Cost analysis backs immediate access to agonist drugs for opioid dependence

November 29, 2017  |  Gary A. Enos, Editor
A cost-effectiveness analysis using California data makes a strong case for significant public investment in methadone and buprenorphine treatment.


Subscribe to Medication